Erlotib is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.

The optimal dosage of Erlotib is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.

Apart from the aforementioned side effects, Erlotib can also lead to other problems, which have been listed below. Usually, these side effects of Erlotib go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.

In addition, Erlotib's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Erlotib's effects on the liver, heart and kidney, if any, have been listed below.

Erlotib is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Lung Disease are examples of such conditions. Other contraindications of Erlotib have been discussed in the sections ahead.

Drug reaction of Erlotib with other medicines has been reported. See below for a complete list.

Along with the above-mentioned precautions, remember that taking Erlotib is considered not safe while driving, and is not addictive.